start portlet menu bar

Visualitzador de contingut web

Display portlet menu
end portlet menu bar

Safety assessment of a single and a repeated dose administration of the inactivated vaccine ERAVAC® in dwarf pet rabbits

Inici Coneixement Safety assessment of a single and a repeated dose administration of the inactivated vaccine ERAVAC® in dwarf pet rabbits

Safety assessment of a single and a repeated dose administration of the inactivated vaccine ERAVAC® in dwarf pet rabbits


The main objective of this study was to evaluate the safety and serological response of ERAVAC® (HIPRA, Spain), an inactivated vaccine for preventing the new variant of rabbit haemorrhagic disease virus (RHDV-2), when administered into dwarf pet rabbits.

Sobre aquest article

Data

18 maig 2018

Autors

Taberner, E.; Ruiz, M. C.; Saün, X.; Woodward, M.; Montbrau, C.

Resum

This study showed that vaccination against RHDV-2 with the licenced vaccine ERAVAC® given to 30- day-old toy dwarf rabbits generates in a low rate transient local signs, while no general signs or important rectal temperature fluctuations were observed. All vaccinated animals responded serologically to ERAVAC® vaccination inducing high antibody response compared to the negative response in the control group.

Productes relacionats

Compartir

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}